An antibody that was developed in the study of multiple sclerosis can stimulate T cells of the immune system so that it attacks some sorts of cancer cells. In models this results in a reduction in tumour growth. This makes the antibody a candidate for a new medication against cancer.
Contact: info(@)neat-news(dot)com.
neat-news.com is not responsible for the content of external sites.
We do not link to external sites in return for money or any other benefits.
Note that photos are usually stock photos, mostly taken from
Wikipedia, which we can use royalty-free either since they are in
the public domain or available under an open licence such as
a share alike licence.
The page is maintained in Germany and for any legal matters the
laws of Germany apply.
Any warranty or liability is excluded in the widest legally
possible sense.
© neat-news.com 2016-2025.